Latest TYBOURNE CAPITAL MANAGEMENT (HK) LTD Stock Portfolio
TYBOURNE CAPITAL MANAGEMENT (HK) LTD Performance:
2025 Q2: 23.1%YTD: -17.73%2024: 8.4%
Performance for 2025 Q2 is 23.1%, and YTD is -17.73%, and 2024 is 8.4%.
About TYBOURNE CAPITAL MANAGEMENT (HK) LTD and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, TYBOURNE CAPITAL MANAGEMENT (HK) LTD reported an equity portfolio of $34.5 Millions as of 30 Jun, 2025.
The top stock holdings of TYBOURNE CAPITAL MANAGEMENT (HK) LTD are FBRX, TSHA, BCYC. The fund has invested 29.4% of it's portfolio in FORTE BIOSCIENCES INC (FBRX US) and 27.4% of portfolio in TAYSHA GENE THERAPIES INC (TSHA US).
The fund managers got completely rid off ACELYRIN INC (SLRN US) stocks. TYBOURNE CAPITAL MANAGEMENT (HK) LTD opened new stock positions in ALUMIS INC (ALMS US) and MALIBU BOATS INC (MBUU US) (MBUU). The fund showed a lot of confidence in some stocks as they added substantially to BICYCLE THERAPEUTICS LTD-ADR (BCYC US) (BCYC), ZENTALIS PHARMACEUTICALS INC (ZNTL US) (ZNTL) and FORTE BIOSCIENCES INC (FBRX US) (FBRX).
The top stock holdings of TYBOURNE CAPITAL MANAGEMENT (HK) LTD are FBRX, TSHA, BCYC. The fund has invested 29.4% of it's portfolio in FORTE BIOSCIENCES INC (FBRX US) and 27.4% of portfolio in TAYSHA GENE THERAPIES INC (TSHA US).
The fund managers got completely rid off ACELYRIN INC (SLRN US) stocks. TYBOURNE CAPITAL MANAGEMENT (HK) LTD opened new stock positions in ALUMIS INC (ALMS US) and MALIBU BOATS INC (MBUU US) (MBUU). The fund showed a lot of confidence in some stocks as they added substantially to BICYCLE THERAPEUTICS LTD-ADR (BCYC US) (BCYC), ZENTALIS PHARMACEUTICALS INC (ZNTL US) (ZNTL) and FORTE BIOSCIENCES INC (FBRX US) (FBRX).
TYBOURNE CAPITAL MANAGEMENT (HK) LTD Annual Return Estimates Vs S&P 500
Our best estimate is that TYBOURNE CAPITAL MANAGEMENT (HK) LTD made a return of 23.1% in the last quarter. In trailing 12 months, it's portfolio return was -10.05%.
New Buys
| Ticker | $ Bought |
|---|---|
| alumis inc (alms us) | 4,197,750 |
| malibu boats inc (mbuu us) | 2,090,540 |
New stocks bought by TYBOURNE CAPITAL MANAGEMENT (HK) LTD
Additions
Additions to existing portfolio by TYBOURNE CAPITAL MANAGEMENT (HK) LTD
Reductions
Sold off
| Ticker | $ Sold |
|---|---|
| acelyrin inc (slrn us) | -7,179,370 |
TYBOURNE CAPITAL MANAGEMENT (HK) LTD got rid off the above stocks
Sector Distribution
TYBOURNE CAPITAL MANAGEMENT (HK) LTD has about 81.8% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 81.8 |
| Others | 12.2 |
| Consumer Cyclical | 6.1 |
Market Cap. Distribution
TYBOURNE CAPITAL MANAGEMENT (HK) LTD has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| SMALL-CAP | 53.4 |
| NANO-CAP | 29.4 |
| UNALLOCATED | 12.2 |
| MICRO-CAP | 5 |
Stocks belong to which Index?
About 11% of the stocks held by TYBOURNE CAPITAL MANAGEMENT (HK) LTD either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 89 |
| RUSSELL 2000 | 11 |
TYBOURNE CAPITAL MANAGEMENT (HK) LTD Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of TYBOURNE CAPITAL MANAGEMENT (HK) LTD
TYBOURNE CAPITAL MANAGEMENT (HK) LTD has 6 stocks in it's portfolio. BCYC proved to be the most loss making stock for the portfolio. FBRX was the most profitable stock for TYBOURNE CAPITAL MANAGEMENT (HK) LTD last quarter.
Last Reported on: 01 Aug, 2025| Ticker | Namesorted descending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| FBRX | forte biosciences inc (fbrx us) | 29.45 | 786,647 | 10,171,300 | added | 26.88 | ||
Historical Trend of FORTE BIOSCIENCES INC (FBRX US) Position Held By TYBOURNE CAPITAL MANAGEMENT (HK) LTDWhat % of Portfolio is FBRX?:Number of FBRX shares held:Change in No. of Shares Held: | ||||||||
| TSHA | taysha gene therapies inc (tsha us) | 27.39 | 4,095,000 | 9,459,450 | added | 10.68 | ||
| BCYC | bicycle therapeutics ltd-adr (bcyc us) | 20.00 | 993,743 | 6,906,510 | added | 72.42 | ||
| alumis inc (alms us) | 12.15 | 1,399,250 | 4,197,750 | new | ||||
| MBUU | malibu boats inc (mbuu us) | 6.05 | 66,705 | 2,090,540 | new | |||
| ZNTL | zentalis pharmaceuticals inc (zntl us) | 4.96 | 1,478,150 | 1,714,660 | added | 53.74 | ||
| acelyrin inc (slrn us) | 0.00 | 0.00 | 0.00 | sold off | -100 | |||
